Search

Your search keyword '"Sager, Philip T."' showing total 79 results

Search Constraints

Start Over You searched for: Author "Sager, Philip T." Remove constraint Author: "Sager, Philip T." Database Unpaywall Remove constraint Database: Unpaywall
79 results on '"Sager, Philip T."'

Search Results

1. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

2. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2

5. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

8. Abstract 11430: Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm

15. Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study

16. Cardiovascular Safety During and After Use of Phentermine and Topiramate

17. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm

19. Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?

24. The Cardiac Safety Research Consortium enters its second decade: An invitation to participate

29. Novel oral anticoagulants and reversal agents: Considerations for clinical development

32. Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: A report from the Cardiac Safety Research Consortium

33. Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes

34. Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus

39. The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

41. Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction

42. Electrocardiographic assessment for therapeutic proteins—scientific discussion

46. Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial

Catalog

Books, media, physical & digital resources